CA Healthcare (CAHC) Revises LumiraDx Deal

CA Healthcare Acquisition Corp. (NASDAQ:CAHC) announced this morning that it is revising its merger with medical device-maker LumiraDx downwards from an enterprise valuation of $5 billion to $3 billion. CA Healthcare said in its press release that this 40% slash in value came due to “the recent market environment for publicly traded diagnostic companies, general
Read More